Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial

Clinical trial NCT07407920 · RECRUITING

Trial details

NCT number: NCT07407920
Sponsor: M.D. Anderson Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Anatomic Stage I Breast Cancer AJCC v8 Anatomic Stage II Breast Cancer AJCC v8 Early Stage HER2-Positive Breast Carcinoma Early Stage Triple-Negative Breast Carcinoma

Start date: 2025-10-09
Primary completion: 2026-09-30
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.